The Company has enclosed herewith intimation for closure of trading window for the quareter ended 30.06.2026

Krebs Biochemicals & Industries Ltd announced the closure of its trading window for dealing in company securities, effective from the close of business hours on June 30, 2026. This closure will remain in effect until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. This measure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and applies to promoters, directors, designated persons, and their immediate relatives.